Recent Patents on Anti-Cancer Drug Discovery

The Anti-Cancer Charm of Flavonoids: A Cup-of-Tea Will Do!
pp. 109-117(9)
Authors: Amr Amin; Michael Buratovich

Histone Deacetylase Inhibitors: A New Wave of Molecular Targeted Anticancer Agents
pp. 119-134(16)
Authors: Alfredo Budillon; Elena Di Gennaro; Francesca Bruzzese; Monia Rocco; Giuseppe Manzo; Michele Caraglia

Mechanisms to Inhibit Matrix Metalloproteinase Activity: Where are we in the Development of Clinically Relevant Inhibitors?
pp. 135-142(8)
Authors: Christian A. Corbitt; Jing Lin; Merry L. Lindsey

Integrin αvβ3 Antagonists for Anti-Angiogenic Cancer Treatment
pp. 143-158(16)
Authors: Andrew R. Hsu; Anand Veeravagu; Weibo Cai; Lewis C. Hou; Victor Tse; Xiaoyuan Chen

Potential of Alphavirus Vectors in the Treatment of Advanced Solid Tumors
pp. 159-166(8)
Authors: Barbara J. Kelly; Marina N. Fleeton; Gregory J. Atkins

Thalidomide Analogues as Anticancer Drugs
pp. 167-174(8)
Authors: Jeanny B. Aragon-Ching; Haiqing Li; Erin R. Gardner; William D. Figg

Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer
pp. 175-186(12)
Authors: Constantinos Mikelis; Marina Koutsioumpa; Evangelia Papadimitriou

Patent Selections
pp. 187-188(2)
Author: Publishers